Grifols S.A. Acc.N.B N.V.(Sp.ADRs)/1 EO-,10

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

22.16%

Market Cap

1.68 Bil.

P/E Ratio

14.03

Dividend Yield

2.44 %

Earnings per Share

0.59 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE6.6 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 08:17:33 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW6.76.35
PREV. DAY'S PRICE6.5 (07/20)
CHANGE DAY BEFORE
+0.10
1.54 %
52 WEEK HIGH / LOW9.3 (07/30)5.8 (07/02)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.090.230.590.851.08
DIVIDENDS PER SHARE
0.000.000.200.250.30
DIVIDEND YIELD IN %
0.00 %0.00 %2.44 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
122.4629.8214.037.495.90
PRICE - BOOK RATIO
1.220.831.03--
PRICE - SALES RATIO
1.100.650.75--
PRICE - CASH FLOW RATIO
34.865.195.39--
Further Key Figures

Master Data

WKN
A1J1E2
ISIN
US3984384087
SYMBOL
G0FB
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
GRIFOLS SP.ADR B EO-,10 1
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
258.22 Mil.
MARKET CAPITALISATION
1.68 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
4.84 %
0.78 %
-7.80 %
-10.34 %
-22.16 %
-28.57 %
-
-12.75 %
HIGH6.556.557.108.159.3010.20-8.15
LOW5.905.805.805.805.804.04-5.80

Dividende

pro Aktie

Company profile

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.